Please assess the completion status of the following clinical trial:

Trial Title: Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Insulin naïve subjects with type 2 diabetes treated with oral hypoglycemic agents~* Body mass index between 26 and 40 kg/m2~* HbA1c between 7.5% and 10.0%~* Fasting plasma glucose \>7.8 mmol/L and fasting C-peptide \> or =0.25 nmol/L

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).